Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Census population 115,451. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Wilmington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Wilmington storefront.
Build Your Biologic Treatment Center in Wilmington, NC for clinics & physicians. Start or expand your biol… Compliance support & pricing — contact Hawk Medical.
Wilmington is a city under 250k (115,451 Census). CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Adult arthritis here is 26% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Build Your Biologic Treatment Center notes (how the product actually works)CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Adult obesity in Wilmington is 31.9% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 26% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JM / Palmetto GBA, sibling states SC, VA, WV. N.C. Department of Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JM articles mapped. 9.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 10.7% of adults — 1.3 points below the U.S. 12% figure. Obesity is 31.9%; arthritis is 26%. That is place-level BRFSS modeling, not a clinic census and not a Wilmington trial.
North Carolina is in CMS MAC JM, administered by Palmetto GBA. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JM FFS, Advantage, workers’ comp, or cash-pay.
No. Hawk Medical LLC is a national distributor founded in 2014. We ship HCT/P 361-compliant tissue, PRP systems, and wound-care biologics to physician practices nationwide, including North Carolina. There is no Wilmington storefront or local street address on this page because we are a service-area distributor, not a walk-in clinic.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Wilmington tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Wilmington, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Wilmington is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Wilmington — 1.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Wilmington. Useful for joint-program math; still needs a diagnosis and privileging.
No Wilmington storefront. Joe Bradley is an active practice owner. biologic treatment center stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.